Vancomycin plus piperacillin-tazobactam is the preferred regimen after amoxicillin-clavulanate failure for cat bite infections.
Rationale for Selection
When amoxicillin-clavulanate fails in a cat bite infection, you must assume either resistant organisms or a deeper/more severe infection requiring broader coverage. The IDSA guidelines explicitly recommend vancomycin plus piperacillin-tazobactam (or a carbapenem) for severe, aggressive soft tissue infections where polymicrobial etiology is suspected 1.
Why the Other Options Fall Short:
Ampicillin-sulbactam is essentially a parenteral equivalent of amoxicillin-clavulanate with similar spectrum. If augmentin failed, ampicillin-sulbactam will likely fail for the same reason—it misses MRSA and some gram-negative rods 1. This represents inadequate escalation.
Bactrim DS (trimethoprim-sulfamethoxazole) has good activity against aerobes but poor activity against anaerobes 1. Cat bites are polymicrobial with significant anaerobic involvement, making this a poor choice. Additionally, it has limited activity against Pasteurella multocida, the most common pathogen in cat bites 2.
Vancomycin plus imipenem-cilastatin provides excellent coverage but is unnecessarily broad for most cat bite failures. While carbapenems are listed as alternatives in the IDSA guidelines 1, they should be reserved for truly resistant organisms or when piperacillin-tazobactam is contraindicated, to preserve this critical antimicrobial class.
Coverage Analysis
Vancomycin plus piperacillin-tazobactam provides:
- MRSA coverage (vancomycin) - critical since augmentin misses MRSA 1
- Broad gram-negative coverage including Pasteurella multocida (piperacillin-tazobactam)
- Anaerobic coverage (piperacillin-tazobactam) - essential for bite wounds 1
- Streptococcal coverage (both agents)
This combination is specifically recommended by IDSA for necrotizing fasciitis and severe soft tissue infections where polymicrobial etiology is suspected 1, which is the appropriate framework for thinking about augmentin failures in cat bites.
Key Clinical Considerations
Cat bites have unique infection characteristics:
- 20-80% infection rate (much higher than dog bites at 3-18%) 3
- Pasteurella multocida carriage rate ~90% in cats 3
- Hand wounds carry greatest infection risk 4
- Puncture wounds penetrate deep structures (tendons, joints, bone)
When augmentin fails, consider:
- Deeper infection (septic arthritis, osteomyelitis, tenosynovitis)
- MRSA or resistant staphylococci (increasingly common in companion animals) 5
- Inadequate source control (abscess requiring drainage)
- Polymicrobial infection with resistant organisms
Dosing
- Vancomycin: 15-20 mg/kg IV every 8-12 hours (target trough 15-20 mcg/mL for serious infections) 6
- Piperacillin-tazobactam: 3.375 g IV every 6 hours or 4.5 g every 8 hours 1
Duration: Typically 7-14 days depending on severity and response, with possible transition to oral therapy once clinically improved 1.
Critical Pitfalls to Avoid
- Don't use monotherapy after augmentin failure—you need both gram-positive (including MRSA) and enhanced gram-negative/anaerobic coverage
- Don't forget surgical evaluation—augmentin failure often signals need for debridement or drainage 1
- Don't use fluoroquinolones alone—they miss anaerobes and some MRSA strains 1
- Don't delay escalation—hand infections can rapidly progress to permanent functional impairment